These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Flupenthixol versus haloperidol in acute psychosis. Parent M; Toussaint C Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372 [TBL] [Abstract][Full Text] [Related]
25. [The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs]. Shoshina II; Shelepin IuE; Semenova NB Fiziol Cheloveka; 2014; 40(1):43-8. PubMed ID: 25272767 [TBL] [Abstract][Full Text] [Related]
26. Fluspirilene in the treatment of non-hospitalized schizophrenic patients. Soni SD Curr Med Res Opin; 1977; 4(9):645-9. PubMed ID: 590024 [TBL] [Abstract][Full Text] [Related]
27. Tilt aftereffect reveals early visual processing deficits in Parkinson's disease and in chronic schizophrenic patients on depot neuroleptic. Calvert JE; Harris JP; Phillipson OT Psychopathology; 1991; 24(6):375-80. PubMed ID: 1685795 [TBL] [Abstract][Full Text] [Related]
28. [Fluspirilene in schizophrenia maintenance therapy and its interaction with dexetimide]. Skopová J; Faltus F; Filip V; Jirák R; Karen P; Posmurová M; Dobiásová A Cesk Psychiatr; 1985 Dec; 81(6):414-9. PubMed ID: 3912068 [No Abstract] [Full Text] [Related]
29. Effect of stimulus orientation on contrast sensitivity in Parkinson's disease. Bulens C; Meerwaldt JD; Van der Wildt GJ Neurology; 1988 Jan; 38(1):76-81. PubMed ID: 3336467 [TBL] [Abstract][Full Text] [Related]
32. [Fluspirilen and fluphenazine in schizophrenic patients. Comparative study]. Magnus RV MMW Munch Med Wochenschr; 1980 Dec; 122(49):1758-60. PubMed ID: 6779147 [No Abstract] [Full Text] [Related]
33. Clinical efficacy of haloperidol in chronic psychotic patients. Lapolla A Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725 [No Abstract] [Full Text] [Related]
34. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241 [TBL] [Abstract][Full Text] [Related]
35. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373 [TBL] [Abstract][Full Text] [Related]
36. The visual system in Parkinson's disease. Bodis-Wollner I; Tagliati M Adv Neurol; 1993; 60():390-4. PubMed ID: 8420159 [No Abstract] [Full Text] [Related]
37. [Depot neuroleptics in indications for tranquilizers: administration forms and risk in neurologic practice]. Schmidt LG Verh Dtsch Ges Inn Med; 1989; 95():713-6. PubMed ID: 2603508 [No Abstract] [Full Text] [Related]
38. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease. Haug BA; Trenkwalder C; Arden GB; Oertel WH; Paulus W Mov Disord; 1994 Sep; 9(5):563-70. PubMed ID: 7990852 [TBL] [Abstract][Full Text] [Related]
39. Fluspirilene (Imap) in the treatment of psychosomatic complaints in hypochondriacal patients. Kalis D; Ten Oever GH; Erdmann JF Acta Psychiatr Belg; 1980; 80(3):321-8. PubMed ID: 7211423 [TBL] [Abstract][Full Text] [Related]